作者：
Hochhaus, A. [1]
;
Rosti, G. [2]
;
Cross, N. C. P. [3]
;
Steegmann, J. L. [4]
;
le Coutre, P. [5]
;
Ossenkoppele, G. [6]
;
Petrov, L. [7]
;
Masszi, T. [8]
;
Hellmann, A. [9]
;
Griskevicius, L. [10]
;
Wiktor-Jedrzejczak, W. [11]
;
Rea, D. [12]
;
Coriu, D. [13]
;
Bruemmendorf, T. H. [14]
;
Porkka, K. [15]
;
Saglio, G. [16]
;
Gastl, G. [17]
;
Mueller, M. C. [18]
;
Schuld, P. [19]
;
Di Matteo, P. [20]
;
Pellegrino, A. [21]
;
Dezzani, L. [22]
;
Mahon, F-X ;
Baccarani, M. ;
Giles, F. J.
作者单位：
Hop St Louis, Serv Hematol Adulte, Paris, France
[1]
Hosp Univ Princesa, IIS IP, Madrid, Spain
[2]
Helsinki Univ Hosp, Ctr Comprehens Canc, Dept Hematol, Helsinki, Finland
[3]
Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Northwestern Med Dev Therapeut Inst, Chicago
[4]
Novartis Oncol Reg Europe, Origgio, Italy
[5]
Univ Victor Segalen, Lab Hematopoiese Leucem & Cible Therapeut, Bordeaux, France
[6]
Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[7]
Ion Chiricuta Inst Oncol, Cluj Napoca, Romania
[8]
Med Univ Gdansk, Gdansk, Poland
[9]
Med Univ Innsbruck, Innere Med, A-6020 Innsbruck, Austria
[10]
Novartis Pharma AG, Basel, Switzerland
[11]
Univ Bologna, Dept Hematol & Oncol, Bologna, Italy
[12]
Heidelberg Univ, Univ Med Mannheim, Mannheim, Germany
[13]
Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Erlanger Allee 101, D-07740 Jena, Germany
[14]
Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[15]
Fundeni Clin Inst, Bucharest, Romania
[16]
Vilnius State Univ, Vilnius Univ Hosp Santariskiu Klin, Vilnius, Lithuania
[17]
Univ Turin, Div Internal Med & Hematol, Orbassano, Italy
[18]
St Istvan & St Laszlo Hosp, Dept Haematol & Stem Cell Transplantat, Budapest, Hungary
[19]
Charite, D-13353 Berlin, Germany
[20]
Med Univ Warsaw, Dept Hematol, Warsaw, Poland
[21]
Univ Klinikum RWTH Aachen, Aachen, Germany
[22]
发布时间
2017-04-06
换一批
